FOLLOW US :
  • |
  • |

Equity

Daily Market Tracker
Market Analysis
Other Markets
Corporate Actions
News
Corporate Information

Corporate Results

Back
Indrayani Biotech consolidated net profit declines 25.41% in the September 2025 quarter
(16-Dec-2025, 07:38 Hours IST)  
Net profit of Indrayani Biotech declined 25.41% to Rs 0.91 crore in the quarter ended September 2025 as against Rs 1.22 crore during the previous quarter ended September 2024. Sales rose 16.68% to Rs 35.95 crore in the quarter ended September 2025 as against Rs 30.81 crore during the previous quarter ended September 2024.

ParticularsQuarter Ended
Sep. 2025Sep. 2024% Var.
Sales35.9530.81 17
OPM %6.8216.59 -
PBDT2.363.99 -41
PBT1.061.20 -12
NP0.911.22 -25

Powered by Capital Market - Live News

IMPORTANT LINKS

QUICK LINKS

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)